SPDR S&P Biotech ETF Sees Unusually High Options Volume (NYSEARCA:XBI)

SPDR S&P Biotech ETF (NYSEARCA:XBI) saw some unusual options trading activity on Friday. Stock traders purchased 73,593 put options on the stock. This is an increase of 25% compared to the typical volume of 58,703 put options.

Institutional Trading of SPDR S&P Biotech ETF

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Synovus Financial Corp raised its position in SPDR S&P Biotech ETF by 110.9% during the third quarter. Synovus Financial Corp now owns 9,391 shares of the exchange traded fund’s stock worth $928,000 after acquiring an additional 4,939 shares during the period. Sanctuary Advisors LLC raised its position in shares of SPDR S&P Biotech ETF by 12.7% during the 3rd quarter. Sanctuary Advisors LLC now owns 15,166 shares of the exchange traded fund’s stock worth $1,460,000 after purchasing an additional 1,711 shares during the last quarter. Pine Valley Investments Ltd Liability Co lifted its stake in SPDR S&P Biotech ETF by 33.0% in the 3rd quarter. Pine Valley Investments Ltd Liability Co now owns 10,387 shares of the exchange traded fund’s stock valued at $1,026,000 after buying an additional 2,577 shares in the last quarter. Westside Investment Management Inc. boosted its holdings in SPDR S&P Biotech ETF by 3.4% in the 3rd quarter. Westside Investment Management Inc. now owns 6,170 shares of the exchange traded fund’s stock worth $610,000 after buying an additional 200 shares during the last quarter. Finally, Invst LLC increased its stake in SPDR S&P Biotech ETF by 6.0% during the 3rd quarter. Invst LLC now owns 2,807 shares of the exchange traded fund’s stock worth $277,000 after buying an additional 160 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

NYSEARCA XBI traded down $1.31 during trading on Friday, reaching $92.89. 7,753,218 shares of the company’s stock traded hands, compared to its average volume of 9,413,228. SPDR S&P Biotech ETF has a 12-month low of $81.14 and a 12-month high of $105.47. The firm has a market cap of $7.08 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. The company’s 50 day simple moving average is $98.13 and its two-hundred day simple moving average is $96.98.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.